The Asia Pacific Aquatic Veterinary Market is projected to grow significantly, reaching an estimated US$ 424.3 million by 2031, up from US$ 312.2 million in 2024. This growth represents a compound annual growth rate (CAGR) of 4.5% from 2025 to 2031.
In addition to government support, companies in the aquatic veterinary sector are actively introducing new products, expanding into new markets, and forming strategic partnerships to strengthen their market positions. The combined efforts of both governmental and business entities create a favorable environment for the growth of aquatic veterinary services in the Asia Pacific region.
These guidelines underscore the importance of veterinary expertise in developing health programs that comply with regulations and in certifying farms for eco-labels such as the Aquaculture Stewardship Council (ASC) and Marine Stewardship Council (MSC). Veterinarians can leverage their knowledge to advise on biosecurity measures, disease-resistant breeding, and welfare protocols, thereby enhancing diagnostic infrastructure and supporting sustainable production for export markets.
The World Veterinary Association's 2024 factsheet on farmed fish welfare highlights the need for veterinarians to lead in establishing standards that minimize antibiotic use and improve transport conditions for aquatic species. This initiative is bolstered by collaborations with the World Aquatic Veterinary Medical Association (WAVMA) for global policy advocacy.
According to a report by the World Aquaculture Society published in December 2024, China's aquaculture production reached 58.10 million tons, accounting for 81.6% of the country's total aquatic product output and approximately 60% of global aquaculture production in 2023. China has established itself as a leading global aquaculture producer, with over 300 aquatic species farmed and a per capita annual consumption of aquatic products reaching 41.2 kg, more than double the world average. Notably, around 25% of the animal protein consumed in China comes from farmed aquatic products.
Chinese aquaculture businesses are increasingly focused on expanding their operations. For instance, in November 2023, Merck Animal Health launched two training modules in its Fish Welfare series to empower aquaculture businesses with best practices for maintaining fish health, aligning with government efforts to standardize veterinary care.
Additionally, Nordic Aqua Partners A/S, a Norwegian company, began constructing China's first land-based salmon farm in December 2020, aiming to produce approximately 36,000 metric tons of salmon annually. The growing seafood consumption in China, coupled with rising aquaculture activities, is driving increased seafood production. However, projections indicate that China may face challenges related to overconsumption of seafood by 2030.
Executive Summary and Market Analysis
The Asia Pacific region, which includes major countries such as China, India, Japan, and Australia, is experiencing rapid growth in its aquatic veterinary market. The primary driver of this growth is the aquaculture industry, which is the largest producer of farmed fish and seafood globally. Governments in the region are increasingly recognizing the economic importance of aquaculture and its role in ensuring food security for their populations. As a result, they are implementing supportive legislation aimed at enhancing the health of aquatic species and improving aquaculture practices. This includes funding for research and development, as well as initiatives to raise awareness about biosecurity and disease control in aquaculture.In addition to government support, companies in the aquatic veterinary sector are actively introducing new products, expanding into new markets, and forming strategic partnerships to strengthen their market positions. The combined efforts of both governmental and business entities create a favorable environment for the growth of aquatic veterinary services in the Asia Pacific region.
Strategic Insights
Market Segmentation Analysis
The Asia Pacific Aquatic Veterinary Market can be segmented in several ways:
- By Type: The market is divided into Diagnostic and Treatment segments, with the Treatment segment leading in 2024.
- By Diagnostic Type: This includes Serological, Molecular Diagnosis, DNA Sequencing, and other diagnostics, with Molecular Diagnosis being the dominant segment in 2024.
- By Treatment Type: The market is segmented into Vaccines, Medications, and Supplements, where Medications held the largest share in 2024.
- By Species: The market includes Fish, Crustaceans, Mollusca, and others, with Fish being the leading segment.
- By Disease Source: This includes Bacterial, Viral, Parasites, and others, with Bacterial diseases dominating the market.
- By Route of Administration: The market is segmented into Water Medication, Medicated Feed, and other routes, with Water Medication being the most prevalent method in 2024.
Market Outlook
The increasing regulatory and consumer emphasis on sustainable aquaculture presents significant opportunities for aquatic veterinarians. They can play crucial roles as consultants and policymakers, influencing health and welfare standards in the industry. Initiatives such as the FAO Guidelines for Sustainable Aquaculture promote practices like recirculating aquaculture systems (RAS) and integrated multi-trophic aquaculture (IMTA), which necessitate health protocols that veterinarians are qualified to design and certify.These guidelines underscore the importance of veterinary expertise in developing health programs that comply with regulations and in certifying farms for eco-labels such as the Aquaculture Stewardship Council (ASC) and Marine Stewardship Council (MSC). Veterinarians can leverage their knowledge to advise on biosecurity measures, disease-resistant breeding, and welfare protocols, thereby enhancing diagnostic infrastructure and supporting sustainable production for export markets.
The World Veterinary Association's 2024 factsheet on farmed fish welfare highlights the need for veterinarians to lead in establishing standards that minimize antibiotic use and improve transport conditions for aquatic species. This initiative is bolstered by collaborations with the World Aquatic Veterinary Medical Association (WAVMA) for global policy advocacy.
Country Insights
The Asia Pacific Aquatic Veterinary Market is further segmented by country, including China, Japan, India, Australia, South Korea, and the Rest of APAC. China is the largest market player, holding a significant share in 2024.According to a report by the World Aquaculture Society published in December 2024, China's aquaculture production reached 58.10 million tons, accounting for 81.6% of the country's total aquatic product output and approximately 60% of global aquaculture production in 2023. China has established itself as a leading global aquaculture producer, with over 300 aquatic species farmed and a per capita annual consumption of aquatic products reaching 41.2 kg, more than double the world average. Notably, around 25% of the animal protein consumed in China comes from farmed aquatic products.
Chinese aquaculture businesses are increasingly focused on expanding their operations. For instance, in November 2023, Merck Animal Health launched two training modules in its Fish Welfare series to empower aquaculture businesses with best practices for maintaining fish health, aligning with government efforts to standardize veterinary care.
Additionally, Nordic Aqua Partners A/S, a Norwegian company, began constructing China's first land-based salmon farm in December 2020, aiming to produce approximately 36,000 metric tons of salmon annually. The growing seafood consumption in China, coupled with rising aquaculture activities, is driving increased seafood production. However, projections indicate that China may face challenges related to overconsumption of seafood by 2030.
Company Profiles
Key players in the Asia Pacific Aquatic Veterinary Market include Thermo Fisher Scientific Inc., Merck KGaA, Zoetis Inc., Virbac SA, Phibro Animal Health Corp, HIPRA SA, Indian Immunologicals Ltd., Esox Biologics Ltd., Ceva Polchem Pvt Ltd., and Aquatic Diagnostics Ltd. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative products to consumers.Table of Contents
1. Introduction
2. Executive Summary
3. Research Methodology
4. Aquatic Veterinary Market Landscape
5. Asia Pacific Aquatic Veterinary Market - Key Market Dynamics
6. Aquatic Veterinary Market - Asia Pacific Market Analysis
7. Asia Pacific Aquatic Veterinary Market Revenue Analysis - by Type
8. Asia Pacific Aquatic Veterinary Market Revenue Analysis - by Diagnostic Type
9. Asia Pacific Aquatic Veterinary Market Revenue Analysis - by Treatment Type
10. Asia Pacific Aquatic Veterinary Market Revenue Analysis - by Species
11. Asia Pacific Aquatic Veterinary Market Revenue Analysis - by Diseases Source
12. Asia Pacific Aquatic Veterinary Market Revenue Analysis - by Route Of Administration
13. Asia Pacific Aquatic Veterinary Market - Country Analysis
14 Competitive Landscape
15 Industry Landscape
16 COMPANY PROFILES
17. Appendix
LIST OF TABLES
LIST OF FIGURES
Companies
The List of Companies - Asia Pacific Aquatic Veterinary MarketThermo Fisher Scientific Inc
Merck KGaA
Zoetis Inc
Virbac SA
Phibro Animal Health Corp
HIPRA SA
Indian Immunologicals Ltd
Esox Biologics Ltd
Ceva Polchem Pvt Ltd
Aquatic Diagnostics Ltd
